(Q46701762)

24 December 2017

title

Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. (English)

1 reference

24 December 2017

2

Stephen T Tiffany

1 reference

24 December 2017

author name string

Vincenzo Teneggi

1

1 reference

24 December 2017

Lisa Squassante

3

1 reference

24 December 2017

Stefano Milleri

4

1 reference

24 December 2017

Luigi Ziviani

5

1 reference

24 December 2017

Alan Bye

6

1 reference

24 December 2017

publication date

22 October 2005

1 reference

24 December 2017

published in

Psychopharmacology

1 reference

24 December 2017

volume

183

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

1-12

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0145-x

exact match

0 references

cites work

Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0145-X

Non-nicotine pharmacotherapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0145-X

Symptoms of tobacco withdrawal. A replication and extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0145-X

Cigarette smoking: implications for psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0145-X

Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group

21 January 2018

1 reference

12 December 2020

Craving is associated with smoking relapse: findings from three prospective studies

1 reference

12 December 2020

Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism

1 reference

12 December 2020

Effects of phenylpropanolamine on withdrawal symptoms

1 reference

12 December 2020

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

1 reference

12 December 2020

Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.

1 reference

12 December 2020

Neurobiological mechanisms of nicotine craving

1 reference

12 December 2020

Neural mechanisms underlying nicotine dependence

1 reference

12 December 2020

Plasma Agmatine and Platelet Imidazoline Receptors in Depressiona

1 reference

12 December 2020

Effect of nicotine on the tobacco withdrawal syndrome

1 reference

12 December 2020

Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.

1 reference

12 December 2020

Prospective study of factors influencing the development of craving associated with smoking cessation.

1 reference

12 December 2020

Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of buspirone in smoking cessation: a placebo-controlled trial

1 reference

12 December 2020

The tobacco withdrawal syndrome in unaided quitters

1 reference

12 December 2020

1 reference

12 December 2020

Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues

1 reference

12 December 2020

The scientific case that nicotine is addictive.

1 reference

12 December 2020

Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment

1 reference

12 December 2020

Relapse prevention for smoking cessation: review and evaluation of concepts and interventions

1 reference

12 December 2020

Measuring tobacco withdrawal: a review of self-report questionnaires

1 reference

12 December 2020

Role of dopamine in the behavioural actions of nicotine related to addiction

1 reference

12 December 2020

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

1 reference

12 December 2020

Time course of smoking withdrawal symptoms as a function of nicotine replacement

1 reference

12 December 2020

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees

1 reference

12 December 2020

New treatments for smoking cessation

1 reference

12 December 2020

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis

1 reference

12 December 2020

Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation

1 reference

12 December 2020

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

1 reference

12 December 2020

Nicotine replacement therapy for smoking cessation

1 reference

12 December 2020

Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal

1 reference

12 December 2020

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

1 reference

12 December 2020

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

1 reference

12 December 2020

Postcessation cigarette use: the process of relapse.

1 reference

12 December 2020

The effect of bupropion sustained-release on cigarette craving after smoking cessation

1 reference

12 December 2020

Effect of Buspirone on Withdrawal Symptoms Associated With Smoking Cessation

1 reference

12 December 2020

Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic

1 reference

12 December 2020

Nicotine replacement therapy. What has been accomplished--can we do better?

1 reference

12 December 2020

A hypothesis for a common neurochemical basis for alcohol and drug disorders.

1 reference

12 December 2020

Predicting smoking cessation. Who will quit with and without the nicotine patch.

1 reference

12 December 2020

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

12 December 2020

Neuroadaptive mechanisms of addiction: studies on the extended amygdala

1 reference

12 December 2020

Process of smoking cessation. Implications for clinicians

1 reference

12 December 2020

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

1 reference

12 December 2020

Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.

1 reference

12 December 2020

Meta-analysis of the efficacy of tobacco counseling by health care providers

1 reference

12 December 2020

Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities

1 reference

12 December 2020

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion

1 reference

12 December 2020

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

1 reference

12 December 2020

The effect of bupropion on nicotine craving and withdrawal.

1 reference

12 December 2020

Comparison of five measures of motivation to quit smoking among a sample of hospitalized smokers

1 reference

12 December 2020

Smoking withdrawal symptoms in two weeks of abstinence

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Neurobiology of addiction. Toward the development of new therapies

1 reference

12 December 2020

The 'nicotine replacement paradox' in smoking cessation: how does nicotine gum really work?

1 reference

12 December 2020

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

12 December 2020

Bupropion is a nicotinic antagonist.

1 reference

12 December 2020

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

1 reference

12 December 2020

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

1 reference

12 December 2020

10.1007/S00213-005-0145-X

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16160876

1 reference

24 December 2017